Self-Distilled Agentic Reinforcement Learning
🤗 Upvotes: 67 | cs.LG, cs.AI, cs.CL
Authors:
Zhengxi Lu, Zhiyuan Yao, Zhuowen Han, Zi-Han Wang, Jinyang Wu, Qi Gu, Xunliang Cai, Weiming Lu, Jun Xiao, Yueting Zhuang, Yongliang Shen
Title:
Self-Distilled Agentic Reinforcement Learning
Arxiv:
http://arxiv.org/abs/2605.15155v1
Abstract:
Reinforcement learning (RL) has emerged as a central paradigm for post-training LLM agents, yet its trajectory-level reward signal provides only coarse supervision for long-horizon interaction. On-Policy Self-Distillation (OPSD) complements RL by introducing dense token-level guidance from a teacher branch augmented with privileged context. However, transferring OPSD to multi-turn agents proves problematic: compounding multi-turn instability destabilizes supervision, while skill-conditioned privileged guidance requires asymmetric treatment for negative teacher rejections may arise from imperfect skills retrieval or utilization. We introduce SDAR (Self-Distilled Agentic Reinforcement Learning), which treats OPSD as a gated auxiliary objective while keeping RL as the primary optimization backbone. SDAR maps detached token-level signals into a sigmoid gate, strengthening distillation on teacher-endorsed positive-gap tokens and softly attenuating negative teacher rejections. Across the Qwen2.5 and Qwen3 families on ALFWorld, WebShop, and Search-QA, SDAR substantially improves over GRPO (+9.4% on ALFWorld, +7.0% on Search-QA, +10.2% on WebShop-Acc), avoids the instability of naive GRPO+OPSD, and consistently outperforms hybrid RL--OPSD baselines across model scales.
You May Also Like

Dumma Människor
Acast - Lina Thomsgård och Björn Hedensjö

Vedanta Cast
Jonas Masetti

The Dissenter
Ricardo Lopes

The Birding Life Podcast Network
The Birding Life Podcast Network

Hillbilly Horror Stories Paranormal Podcast
Jerry Paulley

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra

La Science, CQFD
France Culture

Forschung aktuell
Deutschlandfunk

Hematologic Oncology Update
Dr. Neil Love

Oncology Today with Dr Neil Love
Dr. Neil Love
Community discussion